Press Release / Media Release
Zydus receives two product approvals from the USFDA.15-09-2017
USFDA inspection of Cadila plant
Drug firm Cadila Healthcare today said the US health regulator has issued no observations after completion of inspection of its Moraiya plant in Gujarat. The USFDA has inspected the company's...07-09-2017
Clarifies on news item
With reference to news flashed on CNBC TV 18 dated September 7, 2017 quoting "US FDA issues zero observations post re-inspection of Moraiya unit.", Cadila Healthcare Ltd has submitted to BSE a copy of Clarification is enclosed.07-09-2017
Press Release / Media Release
Cadila Healthcare's Moraiya facility successfully completes USFDA inspection07-09-2017
Clarification sought from Cadila Healthcare Ltd
The Exchange has sought clarification from Cadila Healthcare Ltd on September 7, 2017 with reference to news flashed on CNBC TV 18 dated September 7, 2017 quoting "US FDA issues zero observations post re-inspection of Moraiya unit."".The reply is awaited.07-09-2017
Zydus Cadila gets USFDA nod for injection to patients taking organ transplantation
Cadila Healthcare today said its group firm Zydus Cadila has received final approval from the USFDA to market Mycophenolate mofetil for injection used in organ transplants to prevent rejection....02-09-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Mycophenolate Mofetil for Injection USP02-09-2017
Zydus Cadila gets USFDA nod to market anti-dementia drug
Group now has around 140 approvals and has so far filed over 300 abbreviated new drug applications01-09-2017
Press Release / Media Release
Zydus receives final approval from the USFDA for Donepezil Hydrochloride Tablets.01-09-2017
Zydus Cadila gets USFDA nod for blood clotting drug, shares up over 2%
Zydus Cadila has received approval from the US health regulator to market aspirin and extended release dipyridamole capsules, used to prevent excessive blood clotting and reduce the risk of strokes.30-08-2017